This protocol provides information on how to apply transcutaneous auricular vagus nerve stimulation (taVNS) in a clinical trial, including potential biomarkers such as EEG metrics and heart rate variability (HRV) to measure the effect of this treatment on the autonomic nervous system.
ACERCA DE JoVE
Copyright © 2025 MyJoVE Corporation. Todos los derechos reservados